Add as a preferred source on GoogleHealthcare Companies Beat Q3 EPS Estimates at a 96% Rate
Of 23 companies in the tally, 16 posted year-over-year earnings growth and 21 beat revenue estimates.
In the 23-company tally, 22 companies beat EPS estimates and 21 beat revenue estimates; all 23 posted year-over-year revenue growth.
Sixteen companies, or 70%, had higher earnings than a year earlier. Revenue beat estimates at 21 companies, or 91%, even as every company in the tally recorded year-over-year revenue growth.
Eli Lilly had the strongest revenue growth among the companies highlighted, at 39%, and raised its fiscal 2026 revenue outlook. Regeneron’s revenue increased 36%. AbbVie, Gilead, Biogen and Illumina also raised parts of their fiscal 2026 outlooks.
Amgen, Pfizer, Vertex Pharmaceuticals and Novo Nordisk are among the healthcare companies scheduled to report results next week.
John Kim
John Kim reports on the digital-asset business for TokenPost. Send corrections or tips to info@tokenpost.com.